MoneyWorks4Me

IOL Chemicals and Pharmaceuticals informs about issuance letter of confirmation

21 Nov 2024 Evaluate

In continuation to its earlier intimation of lost share certificates submitted on 5 th November 2024 pursuant to the Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in accordance with the SEBI Notification No. SEBI/LAD-NRO/GN/2022/66 dated 24th January 2022 read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022, IOL Chemicals and Pharmaceuticals has informed that the Company/RTA has issued letter of confirmation dated 21st November 2024 to the shareholders in lieu of the lost share certificates as per details enclosed.

The above information is a part of company’s filings submitted to BSE.

IOL Chem & Pharma Share Price

163.80 6.80 (4.33%)
20-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1181.35
Cipla 1437.65
Lupin 2203.10
Zydus Lifesciences 1108.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: